American Medical Resource Institute | ACLSONLINE.US
Shopping cart
Menu
FDA panel votes to relax restrictions on diabetes drug, Avandia

FDA panel votes to relax restrictions on diabetes drug, Avandia

FDA panel votes to relax restrictions on diabetes drug, Avandia: U.S. health advisers voted to recommend relaxing market restrictions on GlaxoSmithKline's diabetes drug Avandia, the former blockbuster at the center of one of the biggest controversies in recent years. Source found here.